filmov
tv
TAILORx Study Explained by a Medical Oncologist
Показать описание
The Foundation is honored to speak with Dr. Rishi Sawhney, a medical oncologist who practices in Pleasanton, California. The TAILORx study was presented at the 2018 #ASCO (American Society of Clinical Oncology) conference.
Dr. Sawhney describes the group of breast cancer patients enrolled in the study and why these patients may or may not benefit from chemotherapy, based on their Oncotype DX score and depending on the risk group they were in.
He brings up some points of conversation that can be discussed with your breast cancer team. We are grateful for his expertise and comments.
Follow us on:
Dr. Sawhney describes the group of breast cancer patients enrolled in the study and why these patients may or may not benefit from chemotherapy, based on their Oncotype DX score and depending on the risk group they were in.
He brings up some points of conversation that can be discussed with your breast cancer team. We are grateful for his expertise and comments.
Follow us on:
0:05:59
0:33:23
0:01:11
0:01:48
0:07:41
0:33:42
0:01:10
0:01:37
0:04:18
0:04:46
0:03:04
0:05:34
0:05:19
0:05:03
0:00:28
0:15:23
0:03:43
0:01:11
0:47:22
0:05:59
0:00:16
0:04:48
0:12:19
1:13:21